| Autor: |
Şorodoc, Victoriţa, Asaftei, Andreea, Puha, Gabriela, Ceasovschih, Alexandr, Lionte, Cătălina, Sîrbu, Oana, Bologa, Cristina, Haliga, Raluca Ecaterina, Constantin, Mihai, Coman, Adorata Elena, Petriș, Ovidiu Rusalim, Stoica, Alexandra, Şorodoc, Laurenţiu |
| Předmět: |
|
| Zdroj: |
Journal of Personalized Medicine; Jan2023, Vol. 13 Issue 1, p140, 17p |
| Abstrakt: |
Hyponatremia is commonly encountered in the setting of heart failure, especially in decompensated, fluid-overloaded patients. The pathophysiology of hyponatremia in patients with heart failure is complex, including numerous mechanisms: increased activity of the sympathetic nervous system and the renin–angiotensin–aldosterone system, high levels of arginine vasopressin and diuretic use. Symptoms are usually mild but hyponatremic encephalopathy can occur if there is an acute decrease in serum sodium levels. It is crucial to differentiate between dilutional hyponatremia, where free water excretion should be promoted, and depletional hyponatremia, where administration of saline is needed. An inappropriate correction of hyponatremia may lead to osmotic demyelination syndrome which can cause severe neurological symptoms. Treatment options for hyponatremia in heart failure, such as water restriction or the use of hypertonic saline with loop diuretics, have limited efficacy. The aim of this review is to summarize the principal mechanisms involved in the occurrence of hyponatremia, to present the main guidelines for the treatment of hyponatremia, and to collect and analyze data from studies which target new treatment options, such as vaptans. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
